drugset / Trial / NCT00755196

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

NCT00755196

Phase 2 Completed 30 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of AN2728 Ointment, 5%, compared to Ointment Vehicle, applied twice daily for 12 weeks, in the treatment of plaque type psoriasis

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Crisaborole Small molecule 5 % Topical

Indications